The global urology devices market is projected to reach USD 46.4 billion by 2026 from USD 38.0 billion in 2021, at a CAGR of 4.1% during the forecast period. Market growth is driven by factors such as the growing number of hospitals and investments in endoscopy and laparoscopy facilities, rising incidence and prevalence of urological conditions, and growing preference for minimally invasive procedures. On the other hand, the high degree of market consolidation is expected to limit market growth to a certain extent in the coming years.

“The consumables & accessories segment accounted for the highest growth rate in the urology devices market, by product, during the forecast period”
The urology devices market is segmented into instruments and consumables & accessories based on product. In 2020, the consumables & accessories segment accounted for the highest growth rate in the urology devices market. The requirement of consumables and accessories in large numbers as compared to instruments is the major factor contributing to the growth of this segment.

“Urological cancer and BPH segment accounted for the highest CAGR”
Based on applications, the urology devices market is segmented into kidney diseases, urological cancer and BPH, pelvic organ prolapse, and other applications. In 2020, the urological cancer and BPH segment accounted for the highest growth rate. The rising geriatric population and rising incidence of urological cancers are the major factors driving this segment’s growth.

“Dialysis centers segment accounted for the highest CAGR”
Based on end users, the urology devices market is segmented into hospitals, ASCs, and clinics; dialysis centers; and home care settings. In 2020, the dialysis centers segment accounted for the highest growth rate. This can be attributed to the increased demand for advanced dialysis products and facilities for ESRD treatment.

“Asia Pacific: The fastest-growing region urology devices market”
The global urology devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the rising geriatric population, increasing prevalence of diabetes, high burden of kidney diseases such as CKD, increasing healthcare spending, growing per capita income, rising demand for cutting-edge technologies, expansion of private-sector hospitals to rural areas in various APAC countries, and the presence of high-growth markets are driving the growth of the urology devices market in this region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 27%, D-level - 18%, and Others - 55%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%


Research Coverage:
This report provides a detailed picture of the global urology devices market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

  • The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urology devices market and its subsegments.
  • It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.
  • This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, and opportunities.